A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler

Clinical Therapeutics

Volumn 29, Issue 6, 2007, Pages 1013-1026

  Murphy, Kevin ^a   Noonan, Michael ^b   Silkoff, Philip E ^c   Uryniak, Thomas ^c  

^a Midwest Children's Chest Physicians   (United States)

^b Allergy Associates Research Center   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

adolescents; adults; asthma; budesonide inhalation suspension; DPI; inhaled corticosteroids; nebulizer; pMDI

Indexed keywords

BUDESONIDE; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; ASTHMA; BRONCHITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; NOCTURNAL ASTHMA; NOSE CONGESTION; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SINUSITIS; SORE THROAT; STATISTICAL SIGNIFICANCE; SYMPTOM; THRUSH; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANALYSIS OF VARIANCE; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; POWDERS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547611432     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.06.005     Document Type: Article

References (21)

1. National Asthma Education and PRevention Program. Expert panel report: Guidelines for the diagnosis and management of asthma-update on selected topics-2002 [published correction appears in J Allergy Clin Immunol. 2003;111:466]. J Allergy Clin Immunol 110 Suppl 5 (2002) S141-S219
2. Cochrane M., Bala M., Downs K., et al. Inhaled corticosteroids for asthma therapy: Patient compliance, devices, and inhalation technique. Chest 117 (2000) 542-550
3. for the American College of Chest Physicians and the American College of Asthma, Allergy, and Immunology. Dolovich M., Ahrens R., Hess D., et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 127 (2005) 335-371
4. Allen S., and Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly?. Br J Dis Chest 80 (1986) 45-49
5. Connolly M. Inhaler technique of elderly patients: Comparison of metered-dose inhalers and large volume spacer devices. Age Ageing 24 (1995) 190-192
6. Allen S. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 26 (1997) 83-86
7. Baker J., Mellon M., Wald J., et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 103 (1999) 414-421
8. Kemp J., Skoner D., Szefler S., et al. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol 83 (1999) 231-239
9. Pulmicort Respules (budesonide inhalation suspension) [prescribing information] (2007), AstraZeneca LP, Wilmington, Del
10. Shapiro G., Mendelson L., Kraemer M., et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 102 (1998) 789-796
11. Marcus P. The role of nebulized inhaled corticosteroid therapy in adult patients with asthma and chronic obstructive pulmonary disease. Adv Ther 22 (2005) 407-418
12. Higenbottam T., Clark R., Luksza A., et al. The role of nebulised budesonide in permitting a reduction in the dose of oral steroid in persistent severe asthma. Eur J Clin Res 5 (1994) 1-10
13. Otulana B., Varma N., Bullock A., and Higenbottam T. High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Respir Med 86 (1992) 105-108
14. Abstract. O'Connor B., Basran G., O'Connell F., and O'Shaughnessy K. Oral steroid sparing effect of nebulized budesonide in chronic severe asthma. Am J Respir Crit Care Med 153 (1996) A341
15. Connolly K., Peake M., Halpin D., et al. Challenging current asthma treatment guidelines: Improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids. Dis Manag Health Outcomes 7 (2000) 217-225
16. Bisgaard H., Nikander K., and Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respir Med 92 (1998) 44-49
17. Abstract. Gawchik S. Successful treatment of previously uncontrolled adult asthma with budesonide inhalation suspension (Pulmicort Respules™). Ann Allergy Asthma Immunol 88 (2002) 97
18. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
19. Fleiss J. Design and Analysis of Clinical Experiments (1986), John Wiley & Sons, Inc, New York, NY
20. Smith A., Cowan J., Brassett K., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
21. Pulmicort Turbuhaler (budesonide inhalation powder) (2003), AstraZeneca LP, Wilmington, Del